Provide search filter criteria
| Authors | Title | Year | Citation |
|---|---|---|---|
| Precision medicine. | 2019 | Annu Rev Stat Appl. 2019;6():263-286. Pub Med | |
| Efficient estimation of grouped survival models. | 2019 | BMC Bioinformatics. 2019;20(1):269. Pub Med | |
| fastJT: An R package for robust and efficient feature selection for machine learning and genome-wide association studies. | 2019 | BMC Bioinformatics. 2019;20(1):333. Pub Med | |
| Associating somatic mutations to clinical outcomes: a pan-cancer study of survival time. | 2019 | Genome Med. 2019;11(1):37. Pub Med | |
| Joint skeleton estimation of multiple directed acyclic graphs for heterogeneous population. | 2019 | Biometrics. 2019;75(1):36-47. Pub Med | |
| FSEM: Functional structural equation models for twin functional data. | 2019 | J Am Stat Assoc. 2019;114(525):344-357. Pub Med | |
| Time course and prognostic value of serum GFAP, pNFH, and S100β concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion. | 2019 | J Vet Intern Med. 2019;33(2):726-734. Pub Med | |
| Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia. | 2019 | Ann Oncol. 2019;30(4):542-550. Pub Med | |
| Toxicity related to radiotherapy dose and targeting strategy: A pooled analysis of cooperative group trials of combined modality therapy for locally advanced non-small cell lung cancer. | 2019 | J Thorac Oncol. 2019;14(2):298-303. Pub Med | |
| On testing conditional qualitative treatment effects. | 2019 | Ann Stat. 2019;47(4):2348-2377. Pub Med | |
| Effect of Erlotinib plus Bevacizumab vs Erlotinib alone on progression-free survival in patients with advanced EGFR-mutant non–small cell lung cancer: A phase 2 randomized clinical trial. | 2019 | JAMA Oncol. 2019;5(10):1448-1455. Pub Med | |
| Modelling and estimation for optimal treatment decision with interference. | 2019 | Stat (Int Stat Inst). 2019;8(1):. Pub Med | |
| Partition weighted approach for estimating the marginal posterior density with applications. | 2019 | J Comput Graph Stat. 2019;28(2):334-349. Pub Med | |
| False discovery rate control for high dimensional networks of quantile associations conditioning on covariates. | 2018 | J R Stat Soc Series B Stat Methodol. 2018;80(5):1015-1034. Pub Med | |
| Independence screening for high dimensional nonlinear additive ODE models with applications to dynamic gene regulatory networks. | 2018 | Stat Med. 2018;37(17):2630-2644. Pub Med | |
| Genome analysis and pleiotropy assessment using causal networks with loss of function mutation and metabolomics. | 2019 | BMC Genomics. 2019;20(1):395. Pub Med | |
| Endpoint surrogacy in oncological randomized controlled trials with immunotherapies: a systematic review of trial-level and arm-level meta-analyses. | 2019 | Ann Transl Med. 2019;7(11):244. Pub Med | |
| Efficient augmentation and relaxation learning for individualized treatment rules using observational data. | 2019 | J Mach Learn Res. 2019;20():. Pub Med | |
| Efficient methods for signal detection from correlated adverse events in clinical trials. | 2019 | Biometrics. 2019;75(3):1000-1008. Pub Med | |
| Creating an mHealth App for Colorectal Cancer Screening: User-Centered Design Approach. | 2019 | JMIR Hum Factors. 2019;6(2):e12700. Pub Med | |
| Purity independent subtyping of tumors (PurIST), a clinically robust, single-sample classifier for tumor subtyping in pancreatic cancer. | 2020 | Clin Cancer Res. 2020;26(1):82-92. Pub Med | |
| Estimating individualized treatment regimes from crossover designs. | 2020 | Biometrics. 2020;76(3):778-788. Pub Med | |
| A new Bayesian joint model for longitudinal count data with many zeros, intermittent missingness, and dropout with applications to HIV prevention trials. | 2019 | Stat Med. 2019;38(30):5565-5586. Pub Med | |
| Bayesian design of biosimilars clinical programs involving multiple therapeutic indications. | 2020 | Biometrics. 2020;76(2):630-642. Pub Med | |
| Semiparametric regression analysis of multiple right- and interval-censored events. | 2019 | J Am Stat Assoc. 2019;114(527):1232-1240. Pub Med | |
| Analysis of secondary phenotypes in multigroup association studies. | 2020 | Biometrics. 2020;76(2):606-618. Pub Med | |
| Entropy learning for dynamic treatment regimes. | 2019 | Stat Sin. 2019;29(4):1633-1655. Pub Med | |
| Linear hypothesis testing for high dimensional generalized linear models. | 2019 | Ann Stat. 2019;47(5):2671-2703. Pub Med | |
| Assessing tuning parameter selection variability in penalized regression. | 2019 | Technometrics. 2019;61(2):154-164. Pub Med | |
| Consistency and overfitting of multi-omics methods on experimental data. | 2020 | Brief Bioinform. 2020;21(4):1277-1284. Pub Med | |
| Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups. | 2019 | J Biopharm Stat. 2019;29(4):625-634. Pub Med | |
| Genetic analyses of diverse populations improves discovery for complex traits. | 2019 | Nature. 2019;570(7762):514-518. Pub Med | |
| A varying-coefficient generalized odds rate model with time-varying exposure: An application to fitness and cardiovascular disease mortality. | 2019 | Biometrics. 2019;75(3):853-863. Pub Med | |
| Superiority of combining two independent trials in interim futility analysis. | 2020 | Stat Methods Med Res. 2020;29(2):522-540. Pub Med | |
| Estimating the subgroup and testing for treatment effect in a post-hoc analysis of a clinical trial with a biomarker. | 2019 | J Biopharm Stat. 2019;29(4):685-695. Pub Med | |
| A comparison of Monte Carlo methods for computing marginal likelihoods of item response theory models. | 2019 | J Korean Stat Soc. 2019;48(4):503-512. Pub Med | |
| Efficient signal inclusion with genomic applications | 2019 | J Am Stat Assoc. 2019;114(528):1787-1799. Pub Med | |
| Robust score tests with missing data in genomics studies | 2019 | J Am Stat Assoc. 2019;114(528):1778-1786. Pub Med | |
| Proper inference for value function in high-dimensional Q-learning for dynamic treatment regimes. | 2019 | J Am Stat Assoc. 2019;114(527):1404-1417. Pub Med | |
| Longitudinal dynamic functional regression. | 2020 | J R Stat Soc Ser C Appl Stat. 2020;69(1):25-46. Pub Med | |
| Bayesian variable selection for Pareto regression models with latent multivariate log Gamma process with applications to earthquake magnitudes | 2019 | Geosciences (Basel). 2019;9(4):. Pub Med | |
| Determining the number of latent factors in statistical multi-relational learning. | 2019 | J Mach Learn Res. 2019;20():. Pub Med | |
| Network meta-regression for ordinal outcomes: Applications in comparing Crohn's disease treatments. | 2020 | Stat Med. 2020;():. Pub Med | |
| Predictive accuracy of markers or risk scores for interval censored survival data. | 2020 | Stat Med. 2020;39(18):2437-2446. Pub Med | |
| Effective SNP ranking improves the performance of eQTL mapping. | 2020 | Genet Epidemiol. 2020;44(6):611-619. Pub Med | |
| A precision medicine approach to develop and internally validate optimal exercise and weight loss treatments for overweight and obese adults with knee osteoarthritis. | 2021 | Arthritis Care Res (Hoboken). 2021;73(5):693-701. Pub Med | |
| Estimation of treatment effects and model diagnostics with two-way time-varying treatment switching: an application to a head and neck study. | 2020 | Lifetime Data Anal. 2020;26(4):685-707. Pub Med | |
| Tximeta: Reference sequence checksums for provenance identification in RNA-seq. | 2020 | PLoS Comput Biol. 2020;16(2):e1007664. Pub Med | |
| A framework for transcriptome-wide association studies in breast cancer in diverse study populations. | 2020 | Genome Biol. 2020;21(1):42. Pub Med | |
| A Bayesian multi-risks survival (MRS) model in the presence of double censorings. | 2020 | Biometrics. 2020;76(4):1297-1309. Pub Med |